Jump to section
To accelerate medicine for the people who need it, prescribe it, and create it.
Forus, formerly known as Tandem, leverages AI to make accessing medication faster, easier and cheaper for patients. The company handles logistics across doctors, insurers, and pharmacies so that people can get the drugs they need without the normal hassle.
By managing the entire prescription process end-to-end, Forus is eliminating painful administrative work for both patients and doctors. Its streamlined approach means that people can get life-changing therapeutics much quicker and cheaper than through usual processes.
Forus' business model is based on using the network they are building to support life sciences companies in bringing new drugs to market. The data and user connectivity can support pharmaceutical companies with clinical trials, new drug launches, and patient access programs.
Because of this approach, Forus has seen exponential growth, building a large network of users across all 50 states. It's an exciting two-sided model from the company, and one which has seen it raise substantial funding. This supports further expansion across medical specialities.

Kirsty
Company Specialist at Welcome to the Jungle
May 2026
$123m
LATE VC
Jan 2024
$30m
SERIES A
This company has top investors
Sahir Jaggi
(Founder & CEO)Spent 6 years at Oscar Health, ultimately as Director of Product Strategy. Prior to this, they were a Venture Partner at Rough Draft Ventures, Product Manager at Blue Apron and Biomedical Researcher at Columbia University.